ELF3 and gastric cancer: Despite being over-expressed in a sub-set of gastric cancers, ELF3 has functions that are generally associated with tumor suppression such as repressing epithelial-mesenchymal transition (EMT) and promoting the reverse process, mesenchymal to epithelial transition (MET) [45,46].